Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment (original) (raw)
Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum
Eva Klein, Gabriella Sarmay
Proceedings of the National Academy of Sciences, 1985
View PDFchevron_right
Alternative pathway of complement activation by stimulated T lymphocytes I. Binding of C3 fragments
Eva Klein, Gabriella Sarmay
European Journal of Immunology, 1987
View PDFchevron_right
Contribution of activated C3 to lymphocyte-mediated target lysis: Complement-dependent cellular cytotoxicity
Gabriella Sarmay
Molecular Immunology, 1984
View PDFchevron_right
Complement Receptor Distinguishes between Two Subsets of Large Granular Lymphocytes with Different Natural Killer Activity and Cytochemical and Ultrastructural Features
Piero Balbo
Scandinavian Journal of Immunology, 1983
View PDFchevron_right
Binding of fluid-phase complement components C3 and C3b to human lymphocytes
Edith Sim
Biochemical Journal, 1981
View PDFchevron_right
A new role for complement C3: Regulation of antigen processing through an inhibitory activity
Christian Villiers
Molecular Immunology, 2008
View PDFchevron_right
Specific Inactivation of the Fourth Complement Component II. In Vitro Studies
Mary Luz Emilianis Garces
Infection and Immunity, 1971
View PDFchevron_right
Derivatives of Human Complement Component C3 for Therapeutic Complement Depletion: A Novel Class of Therapeutic Agents
James Newhouse
Advances in Experimental Medicine and Biology, 2008
View PDFchevron_right
Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model
D. Fritzinger
Blood, 2009
View PDFchevron_right
Specific Inactivation of the Fourth Complement Component I. In Vivo Studies
Mary Carmen Santelices Garces
Infection and Immunity, 1971
View PDFchevron_right
Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes
Gabriella Sarmay, Anna Erdei
Clinical immunology and immunopathology, 1977
View PDFchevron_right
Study on the Turnover of the Receptor for the Third Component of Complement on Human Lymphoid Cells
Claudio Fortis
The Journal of Immunology
View PDFchevron_right
The role of complement in the induction and regulation of immune responses
D. Befus
Immunology, 1984
View PDFchevron_right
Complement receptors on lymphocytes
Christian Villiers
Journal of Cancer Research and Clinical Oncology, 1981
View PDFchevron_right
Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays
John d. Lambris, József Prechl, Anna Erdei
Molecular Immunology, 2004
View PDFchevron_right
Elevated NK sensitivity of Raji cells carrying acceptor-bound C3 fragments
Gabriella Sarmay
Cellular Immunology, 1988
View PDFchevron_right
TWO DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTES: ONE SPECIFIC FOR C3b AND ONE SPECIFIC FOR C3b INACTIVATOR-CLEAVED C3b
Enrique Rabellino
Journal of Experimental Medicine, 1973
View PDFchevron_right
Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2)
Edith Sim
Biochemical Journal, 1984
View PDFchevron_right
In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5
Dennis Wolff
Molecular Immunology, 1995
View PDFchevron_right
Therapeutic control of complement activation at the level of the central component C3
John Lambris
Immunobiology, 2016
View PDFchevron_right
Immunoblotting analysis of the peptide chain structure of the physiological breakdown products of the third component of human complement
jørgen Folkersen
Electrophoresis, 1986
View PDFchevron_right
Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937
Christian Villiers
The Biochemical journal, 1989
View PDFchevron_right
Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity
Stephen Tomlinson
Blood, 2002
View PDFchevron_right
Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans
Panca Dewi Purwati
Frontiers in Immunology, 2020
View PDFchevron_right
Studies of complement receptors on cytotoxic effector cells in human peripheral blood
John M Vierling
Cellular Immunology, 1978
View PDFchevron_right
Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes
Gabriella Sarmay, Anna Erdei
Clinical immunology and immunopathology, 1976
View PDFchevron_right
Purification of human complement subcomponent C4. C4 cleavage by C1s
N. Thielens
FEBS letters, 1979
View PDFchevron_right
Complement Activation: The role in Health and Disease and Strategies of Therapeutic Complement Inhibition
Nurun Nahar Mawla
American Journal of Medical Sciences and Medicine, 2014
View PDFchevron_right
Complement Inhibitors Targeting C3, C4, and C5
John Lambris
Therapeutic Interventions in the Complement System, 2000
View PDFchevron_right